"On what we have seen to date, we believe that DARRT therapy has...

"On what we have seen to date, we believe that DARRT therapy has the potential to go on to become a disruptive cancer treatment across most forms of cancer"


I research and invest in a lot of oncology biotechs. I'm excited about many of them. Some show a lot of promise, and many have been very profitable already. But every single on of them focuses on small specific subtypes, mutations, targets, populations, etc.

So I honestly believe that the industry cannot wrap it's head around the potential scale of NOX. Being applicable to not only radiotherapy, but chemo, immuno.... across multiple types of cancer.

And now that DARRT regime has US patent protection, it's almost a formality that patent protection can be achieved for all of the combinations.

Opportunity of the century.